Tether has invested $200 million in Blackrock Neurotech, a biotechnology company that develops tools to assist people with paralysis, loss of function, and neurological disorders. This investment was made through Tether Evo, a new division of Tether.
With this investment, Tether now becomes the largest shareholder of Blackrock Neurotech. Tether also did not forget to mention that this is an investment from the company's profits, not using collateral for USDT.